 NEW YORK, Dec. 22, 2020 GLOBE NEWSWIRE -- Royalty Pharma plc Nasdaq: RPRX today announced charitable contributions totaling 7,660,000 to support important COVID-19 research at The Rockefeller University, Mount Sinai Health System and Columbia University. This amount includes donations from Royalty Pharma plc of 4,880,000 and personal contributions from Pablo and Almudena Legorreta of 2,880,000. Neither Royalty Pharma plc nor Pablo and Almudena Legorreta will receive any economic benefit in exchange for any aspect of these donations. 